Oge Energy Corp.
$15.34B- Market cap
- $9.68B
- Debt
- +$5.66B
- Cash
- −$200.00K
Capital structure 63% equity / 37% debt · EV / Revenue 4.71x · EV / EBITDA 9.95x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 ·
Decision snapshot: OGE stock price at discount vs AMRX $46.92 current versus $184.12 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at AMRX's multiple
Implied fair value · at OGE's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Value edge
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: OGE FY 2025 (ended Dec 31, 2025) · AMRX FY 2025 (ended Dec 31, 2025).
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 63% equity / 37% debt · EV / Revenue 4.71x · EV / EBITDA 9.95x
Capital structure 68% equity / 32% debt · EV / Revenue 2.61x · EV / EBITDA 15.60x
OGE carries the larger enterprise value at $15.34B against $7.87B; AMRX trades on the lower EV / Revenue multiple (2.61x vs 4.71x); OGE on the lower EV / EBITDA (9.95x vs 15.60x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
OGE ENERGY CORP. · implied price per share
At least 3 of the last 5 annual free-cash-flow observations must be positive.
AMNEAL PHARMACEUTICALS, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.14x
-36.42x
Net debt / EBITDA
Leverage against operating earnings
3.67x
4.55x
Cash and equivalents
Liquid reserves on the balance sheet
$200.00K
$282.03M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
$5.66B
$2.58B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.